Market Cap 992.61M
Revenue (ttm) 0.00
Net Income (ttm) -122.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 839,700
Avg Vol 827,910
Day's Range N/A - N/A
Shares Out 57.34M
Stochastic %K 25%
Beta -2.35
Analysts Strong Sell
Price Target $81.00

Latest News on GPCR

Structure Therapeutics CEO on latest GLP-1 developments

Mar 24, 2025, 6:26 PM EDT - 10 days ago

Structure Therapeutics CEO on latest GLP-1 developments


Final Trade: PYPL, UBER, NKE, GPCR

Mar 24, 2025, 6:23 PM EDT - 10 days ago

Final Trade: PYPL, UBER, NKE, GPCR

NKE PYPL UBER


Structure Therapeutics CEO on GLP drugs

Jun 11, 2024, 6:37 PM EDT - 10 months ago

Structure Therapeutics CEO on GLP drugs


Structure Therapeutics reports promising weight-loss drug data

Jun 3, 2024, 2:38 PM EDT - 10 months ago

Structure Therapeutics reports promising weight-loss drug data


Structure Therapeutics stock plunges on new GLP-1 drug data

Dec 18, 2023, 8:04 AM EST - 1 year ago

Structure Therapeutics stock plunges on new GLP-1 drug data


Final Trades: Rivian, Pfizer, Treasury Bonds and more

Sep 29, 2023, 6:26 PM EDT - 1 year ago

Final Trades: Rivian, Pfizer, Treasury Bonds and more

PFE RIVN TLT


Structure Therapeutics Appoints Ted W. Love, M.D.

Aug 3, 2023, 5:32 PM EDT - 1 year ago

Structure Therapeutics Appoints Ted W. Love, M.D.